[3]
By Judith Siers Poisson
The three previous articles in this series have examined the Politics and PR of Cervical Cancer in the United States. This fourth and final installment will look at how Merck's so-called "cervical cancer vaccine," Gardasil, is being marketed in Canada, Australia, and New Zealand.